Sign up
All nephrology trends
SteadyNephrology · updated 18 Oct 2026

Home dialysis

Home haemodialysis and peritoneal dialysis.

Key point

Core interventions to reduce PD-related infections focus on surveillance, standardized staff and patient training, infection prevention assessments, and antimicrobial prophylaxis.

From: Core Interventions for the Prevention of Peritoneal Dialysis-Related Infections (Clin J Am Soc Nephrol, 2026 Aug 1) ↗
40PubDaily Trend Score
+5%new papers vs last year
62new trials registered
9new guidelines this year

Papers per year

Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 40, 34, 52, 53, 62.

New guidelines and consensus this year

  1. Joint International Society of Renal Nutrition and Metabolism (ISRNM) and International Society for Peritoneal Dialysis (ISPD) Practice Recommendation on Nutrition Management in Peritoneal Dialysis
    J Ren Nutr2026 Sep
  2. Joint International Society of Renal Nutrition and Metabolism (ISRNM) and International Society for Peritoneal Dialysis (ISPD) practice recommendation on nutrition management in peritoneal dialysis
    Perit Dial Int2026 Sep
  3. Core Interventions for the Prevention of Peritoneal Dialysis-Related Infections
    Clin J Am Soc Nephrol2026 Aug 1
  4. Position Statement of the Brazilian Society of Nephrology on incremental dialysis
    J Bras Nefrol2026 Jul-Sep
  5. 2026 ISPD Position Statement on tracking and reporting loss from PD therapy
    Perit Dial Int2026 Jun 17

All papers from the last 12 months

1,458 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…

Open this search in PubMed
  1. Machine learning-assisted photoelectrochemical aptasensor for nalbuphine monitoring using a BiOBr/SrWO(4) S-scheme heterojunction
    Talanta2027 Jan 1PMID 42442233
  2. Analytical and clinical impact of bilirubin and glucose interference in Siemens Jaffé and enzymatic creatinine assays
    Clin Chim Acta2027 Jan 1PMID 42320663
  3. Alteration of gut microbiota contributes to peritoneal fibrosis through increased production of trimethylamine N-oxide
    Gut Microbes2026 Dec 31PMID 41983510
  4. Multicomponent analysis of dialysis fluid for enhanced biomedical monitoring through FT-IR spectroscopy
    Spectrochim Acta A Mol Biomol Spectrosc2026 Dec 5PMID 42242153
  5. Efficacy and safety of roxadustat for the treatment of renal anemia in patients undergoing peritoneal dialysis: a systematic review and meta-analysis
    Ren Fail2026 DecPMID 42838123Meta-analysisSystematic review
  6. Development and validation of a nomogram for peritoneal dialysis-associated peritonitis
    Ren Fail2026 DecPMID 42823121
  7. Effects of automated peritoneal dialysis and continuous ambulatory peritoneal dialysis on residual kidney function in Chinese patients with new-onset end stage kidney disease
    Ren Fail2026 DecPMID 42802590
  8. An approach to treat refractory catheter-related infections in patients undergoing peritoneal dialysis: tunnel-reconstruction operation
    Ren Fail2026 DecPMID 42768893
  9. Outcomes of pediatric urgent-start peritoneal dialysis: a single-center experience from Jordan
    Ren Fail2026 DecPMID 42768298
  10. Dialysis deserts in the Philippines: a national geospatial modeling study of dialysis services
    Glob Health Action2026 DecPMID 42703736

More nephrology trends

All specialties →

Lupus nephritis

Rising
+18%new papersScore 61
20212026

Kidney involvement in lupus and its newer treatments.

Key point: Lupus nephritis management is increasingly individualized, with expanding treatment options, combination therapy, and a trend toward lower corticosteroid doses.

1,129 papers / yr53 new trials6 new guidelines
See all papers →

Complement inhibitors in kidney disease

Steady
+38%new papersScore 44
20212026

Iptacopan, avacopan and other complement inhibitors in glomerular disease.

Key point: Complement inhibitors had no overall effectiveness or safety advantage over plasma therapy in atypical hemolytic uremic syndrome, except lower relapse rates.

209 papers / yr6 new trials1 new guideline
See all papers →

APOL1 kidney disease

Steady
+5%new papersScore 40
20212026

Kidney disease linked to APOL1 gene variants.

127 papers / yr1 new trials1 new guideline
See all papers →

HIF-PH inhibitors for anaemia

Steady
-8%new papersScore 33
20212026

Oral drugs such as roxadustat for anaemia of kidney disease.

Key point: HIF-PHIs such as roxadustat are reserved for non-dialysis CKD when erythropoiesis-stimulating agents are unsuitable, given potential risks and limited long-term data.

149 papers / yr9 new trials1 new guideline
See all papers →

Race-free eGFR

Steady
+1%new papersScore 33
20212026

Kidney function equations without a race coefficient.

151 papers / yr27 new trials
See all papers →

Pig kidney xenotransplantation

Steady
0%new papersScore 25
20212026

Transplanting genetically modified pig kidneys into humans.

113 papers / yr4 new trials
See all papers →

Too many papers to read?

PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.

Get started
How these numbers are counted

PubMed query, searched in titles and abstracts by publication date:

"home dialysis"[tiab] OR "home hemodialysis"[tiab] OR "peritoneal dialysis"[tiab]

Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.